Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Pioneer Institute Launching Center to Push Issues in Court (CommonWealth Magazine)

Related Content

PTAB’s Reversal Sheds Light on Quantum Computing Patents

Four Steps to Maximize the Value of AI Innovation in Medtech

Five Steps Hotel Owners, Operators, and Management Companies Can Take to Mitigate Risk in the Face of Heightened Antitrust Scrutiny and a Wave of Lawsuits Involving Revenue-Management Tools

Life Sciences Licensing and M&A Update: Catching Up on Recent Decisions Affecting Commercially Reasonable Efforts Definitions and Post-Patent Expiration Royalty Obligations

The Rapid Rise of AI, in Five Charts

U.S. Supreme Court Significantly Curtails SEC Enforcement Forum Discretion

JAMS Release Mass Arbitration Procedures Following AAA’s Lead

Lawsuit Filed Challenging FDA Final Rule Regulating Laboratory Developed Tests

The Legal 500 US 2025 Recognizes 44 Goodwin Practices and 172 Lawyers

2025 FDLI Annual Conference

Kronos Bio To Be Taken Private by Concentra Biosciences

Goodwin Secures Complete Victory for Insulet Corporation with $60 Million Award and Worldwide Permanent Injunction

SpringWorks Therapeutics To Be Acquired By Merck KGaA, Darmstadt, Germany For $3.9 Billion

Laura Stoll Recognized by The Los Angeles Business Journal’s Top 100 Lawyers of 2025

Six Goodwin Lawyers Named to Law360’s 2025 Editorial Advisory Boards

2seventy bio To Be Acquired by Bristol Myers Squibb for $5.00 per Share

Litigation

Complex Litigation & Dispute Resolution